Purpose Sotatercept, an activin signalling inhibitor approved in March 2024 for pulmonary arterial hypertension (PAH), ...
Overview: In 2025, data analytics tools blend AI, cloud, and automation for real-time insights and smarter decisions.Tableau, ...
BACKGROUND: Alternative splicing plays crucial roles in normal heart development and cardiac disease by influencing protein-coding sequences, functional domains, and molecular networks. However, a ...
Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...
A new study explores “heartbeat consumption,” a fitness metric that counts daily heartbeats. Could smartwatches soon track your heartbeat budget?
Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...
Improving the analysis of cardiovascular imaging for better patient care. Circle Cardiovascular Imaging (Circle) is a ...
Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has developed a new type of contactless body data ...
Amgen received a label expansion from the FDA in August 2025, with the VESALIUS-CV data supporting this decision. Amgen is ...
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Recovery Compared to ...
Based on new evidence, the World Health Organization has released new guidelines for excessive bleeding after birth.